Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3

Oncogene

Volumn 18, Issue 52, 1999, Pages 7576-7583

  Yin, Zhengnan ^a   Spitz, Margaret R ^a   Babaian, Richard J ^a   Strom, Sara S ^a   Troncoso, Patricia ^a   Kagan, Jacob ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chromosome 13; Loss of heterozygosity; Prostate cancer; Tumor suppressor gene

Indexed keywords

DNA MARKER; MICROSATELLITE DNA;

ARTICLE; CHROMOSOME 13Q; CONTROLLED STUDY; GENE LOCATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE;

EID: 0033539942     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203203     Document Type: Article

References (49)

1. Bergerheim US, Kunimi K, Collins VP and Ekman P. (1991). Genes, Chromosomes Cancer, 3, 215-220.
2. Bookstein R, Rio P, Madreperla SA, Hong F, Allred C, Grizzle EW and Lee WH. (1990). Proc. Natl. Acad. Sci. USA, 87, 7762-7766.
3. Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC. Epstein JI, Walsh PC and Issacs WB. (1993). Cancer Res., 53, 3869-3873.
4. Brewster SF, Browne S and Brown KWZ. (1994). J. Urol., 151, 1073-1077.
5. Brooks JD, Bova GS and Issacs WB. (1995). Prostate, 26, 35-39.
6. Brooks JD, Bova SG, Ewing CM, Piantadosi S, Carter BS, Robinson JC, Epstein JI and Issacs WB. (1996). Cancer Res., 56, 3814-3822.
7. Brown AG, Ross FM, Dunne EM, Steel CM and Weir-Thompson EM. (1993). Nat. Genet., 3, 67-72.
8. Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Issacs PW, Bova SG and Sidransky D. (1997). Cancer Res., 57, 4997-5000.
9. Carter BS, Ewing CM, Ward WS, Treioger BF, Aalders TW, Schalken JA, Epstein JI and Isaacs WB. (1990). Proc. Natl. Acad. Sci. USA, 87, 8751-8755.
10. Collins A, Frezal J, Teague J and Morton NE. (1996). Proc. Natl. Acad. Sci. USA, 93, 14771-14775.
11. Cooney KA, Wetzel JC, Merajver SD and Macoska JA. (1996). Cancer Res., 56, 1142-1145.
12. Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, Qian J, Takahashi S, Jenkins RB, Bostwick DG and Thibodeau SN. (1996). Cancer Res., 56, 4475-4482.
13. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Sebon E, Lathrop M, Gyapay G, Morissette J and Weissenbach J. (1996). Nature, 380, 152-154.
14. Fleming ID, Cooper JS, Henson DE, Huntter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH and Yarbro JW (eds). (1997). AJCC Cancer Staging Manual, 5th edition, Lippincott-Raven, Philadelphia: New York.
15. Gleason D. (1977). Urologic Pathology: The prostate. Tannenbaum M (ed.). Lea & Febiger: Philadelphia, pp. 171-197.
16. Gudmundsson J, Johannesdottir ZG, Bergthorsson JT, Aaronson A, Ingvarsson S, Egilsson V and Barkardottir RB. (1995). Cancer Res., 55, 4830-4832.
17. Kagan J, Stein J, Babaian RJ, Joe Y, Pisters LL, Glassman AB, von Eschenbach AC and Troncoso P. (1995). Oncogene, 11, 2121-2126.
18. Kerangueven F, Allione F, Noguchi T, Adelaide J, Sobol H, Jacquemier J and Birinbaum D. (1995). Genes, Chromosomes Cancer, 13, 291-294.
19. Kunimi K, Bergerheim USR, Larsson IL, Ekman P and Collins VP. (1991). Genomics, 11, 530-536.
20. Landis SH, Murray T, Bolden S and Wingo PA. (1999). CA: Cancer J. Clin., 4, 8-31.
21. Latil A, Baron JC, Cussento O, Fournier G, Soussi T, Boccon-Gbod L, Le Duc A, Rouse J and Lidereau R. (1995). Bulletin de Cancer, 82, 589-597.
22. Li C, Larsson C, Futreal A, Lancaster J, Phelan C, Aspenblad U, Sundelin B, Liu Y, Ekman P, Auer G and Bergerheim USR. (1998). Oncogene, 16, 481-487.
23. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Itterman M, Tycko B, Hibshoosh H, Wigler MH and Parsons R. (1997). Science, 275, 194-197.
24. Liu Y, Corcoran M, Rasool O, Ivanova G, Ibbotson R, Grander D, Iyengar A, Baranova A, Kashuba V, Merup M, Wu X, Gardiner A, Mullenbach R, Poltaraus A, Hultstrom AL, Juliusson G, Chapman R, Tiller M, Cotter F, Gahrton G, Yankovsky N, Zabarovsky E, Einhorn S and Oscier D. (1997). Oncogene, 15, 2463-2473.
25. MacGrogan D, Levy A, Bostwick D, Wagner M, Wells D and Bookstein R. (1994). Genes, Chromosomes Cancer, 10, 151-159.
26. Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ, Wojno KD, Pietruk T and Powell IJ. (1995). Cancer Res., 55, 5390-5395.
27. Mastero R, Piccinin S, Doglioni C, Gasparotto D, Vukosavljevic T, Sulfaro S, Barzan L and Biocchi M. (1996). Cancer Res., 56, 1146-1150.
28. Melamed J, Einhorn JM and Ittmann MM. (1997). Clin. Cancer Res., 3, 1867-1872.
29. Mottaz AE, Markwalder R, Fey MF, Klima I, Merz VW, Thalmann GN, Ball RK and Studer UE. (1997). Prostate, 31, 209-215.
30. Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC and Conti CJ. (1993). Natl. Cancer Inst., 85, 1657-1669.
31. Pearce SH, Trump D, Woodding C, Sheppard MN, Clayton RN and Thakker RV. (1996). Clin. Endocrinol., 45, 195-200.
32. Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF and Prager D. (1995). Cancer Res., 55, 1613-1616.
33. Phillips SM, Morton DG, Lee SJ, Wallace DM and Neoptolemos JP. (1994). Br. J. Urol., 73, 390-395.
34. Salem CE, Tonasic NA, Elmajian DA, Esring D, Nichols PW, Taylor CR, Skinner DG, Roy-Burman P, Lieskovsky G and Cote RJ. (1997). J. Urol., 158, 510-514.
35. Sarkar FH, Sakr W, Macoska J, Ball DE and Crissman JD. (1992). Prostate, 21, 145-152.
36. Sigurdsson S, Thorlaciius S, Tomasson J, Tryggvadottir L, Benediktsdottir K, Eyfjord JE and Jonsson E. (1997). J. Mol. Med., 75, 758-761.
37. Steck PA, Pershouse MA, Jasser SA, Yung WAK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF and Tavtigian SV. (1997). Nat. Genet., 15, 356-362.
38. Suzuki H, Emi M, Komiya A, Fujiwara Y, Yatani R, Nakamura Y and Shimazaki J. (1995). Genes, Chromosomes Cancer, 13, 168-174.
39. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Issacs WB and Bova SG. (1998). Cancer Res., 58, 204-209.
40. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF and Goldgar DE. (1996). Nat. Genet., 12, 333-337.
41. Teng DH-F, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WKA, Fujii G, Berson A, Bookstein R, Bolen JB, Tavtigian SV and Steck P. (1997). Cancer Res., 57, 5221-5225.
42. Trapman J, Sleddens HFBM, van der Weiden MM, Dinjens WMM, Koning JJ, Schroder FH, Faber PW and Bosman FT. (1994). Cancer Res., 54, 6061-6064.
43. Ueda T, Komiya A, Emi M, Suzuki H, Shiraishi T, Yatani R, Masai M, Yasuda K and Ito H. (1997). Genes, Chromosomes Cancer, 20, 140-147.
44. Visakorpi T, Kallioniemi AH, Syvanen AC, Hytinen ER, Karhu R, Tammela T, Isola JJ and Kallioniemi OP. (1995). Cancer Res., 55, 342-347.
45. Weinberg RA. (1991). Science, 254, 1138-1146.
46. Weinstein IB. (1996). J. Cell. Biochem., 25, 23-28. [Suppl].
47. Yoo GH, Xu HJ, Breennan JA, Westra W, Hruban RH, Koch W, Benedict WF and Sidransky D. (1994). Cancer Res., 54, 4603-4606.
48. Zar JH. (1991). Biostatistical Analysis. Prentice Hall: Englewood Cliffs, NJ.
49. Zenklusen JC, Thompson JC, Troncoso P, Kagan J and Conti CJ. (1995). Cancer Res., 54, 6370-6373.